Moderna Completes Application for FDA Approval of COVID-19 Vaccine
- August 27, 2021
Moderna Inc. has completed its Biologics Licensing Application (BLA) seeking full approval from the Food and Drug Administration (FDA) of its two-dose messenger RNA (mRNA) vaccine to prevent COVID-19 in individuals 18 years of age and older, the company announced August 25.
ARTICLE TAGS
You must be logged in to access this content.